Published in Brain Res on October 01, 1969
Studies on ectopic granule cells in the cerebellar cortex--with a hypothesis as to their aetiology and pathogenesis. Acta Neuropathol (1972) 1.10
Ectopic neurones in the hippocampus of the postnatal rat exposed to methylazoxymethanol during foetal development. Acta Neuropathol (1977) 1.03
Deformed dendrites and reduced spine numbers on ectopic neurones in the hippocampus of rats exposed to methylazoxymethanol-acetate. A Golgi-Cox study. Acta Neuropathol (1980) 0.90
Formation of heterotopic granule cell in mouse cerebellum after neonatal administration of cytosine arabinoside. Acta Neuropathol (1980) 0.89
Destruction of external granular layer and subsequent cerebellar abnormalities. Acta Neuropathol (1983) 0.85
Brain vascular endothelial cells express JC virus large tumor antigen in immunocompetent and cyclophosphamide-treated hamsters. Proc Natl Acad Sci U S A (1992) 0.78
Effects of viral infection on nervous system development. II. Attempts to modify bluetongue-virus-induced malformations with cyclophosphamide and antithymocyte serum. Am J Pathol (1972) 0.77
The structural organization of layer IV in the somatosensory region (SI) of mouse cerebral cortex. The description of a cortical field composed of discrete cytoarchitectonic units. Brain Res (1970) 7.33
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature (1982) 2.64
Seasonality and the requirements for perpetuation and eradication of viruses in populations. Am J Epidemiol (1979) 2.58
Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob Agents Chemother (1994) 2.46
Somatosensory cortex: structural alterations following early injury to sense organs. Science (1973) 2.43
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Analysis of thick brain sections by obverse-reverse computer microscopy: application of a new, high clarity Golgi-Nissl stain. J Neurosci Methods (1981) 2.29
Synaptogenesis in human visual cortex--evidence for synapse elimination during normal development. Neurosci Lett (1982) 2.26
Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature (1968) 2.16
Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur J Immunol (1986) 2.06
The genetics of susceptibility to multiple sclerosis. Epidemiol Rev (1982) 2.00
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest (1976) 1.96
The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. Am J Epidemiol (1979) 1.87
Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein. Virology (1983) 1.86
Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res (1970) 1.79
Human exposure to SV40: review and comment. Am J Epidemiol (1976) 1.77
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys. Clin Exp Immunol (1970) 1.61
The effect of soft cervical collars on persistent neck pain in patients with whiplash injury. Acad Emerg Med (1996) 1.61
Hepatitis B infection in households of chronic carriers of hepatitis B surface antigen: factors associated with prevalence of infection. Am J Epidemiol (1982) 1.60
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis (1974) 1.51
Lymphocytic choriomeningitis. Pathogenesis. Prog Med Virol (1974) 1.47
Autapses in neocortex cerebri: synapses between a pyramidal cell's axon and its own dendrites. Brain Res (1972) 1.45
Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus. Lab Invest (1984) 1.44
Experimental infection of monkeys with Langat virus II. Turnover of circulating virus, 1967. Rev Med Virol (2000) 1.42
Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest (1976) 1.42
Eradication of poliomyelitis in the United States. Rev Infect Dis (1983) 1.42
Organization of the projections from barrel cortex to thalamus in mice studied with Phaseolus vulgaris-leucoagglutinin and HRP. Exp Brain Res (1987) 1.40
Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. J Exp Med (1975) 1.37
Antibody-selected variation and reversion in Sindbis virus neutralization epitopes. J Virol (1986) 1.35
Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages. J Hyg (Lond) (1970) 1.34
Pathogenesis of West Nile Virus encepahlitis in mice and rats. II. Virus multiplication, evolution of immunofluorescence, and development of histological lesions in the brain. Am J Epidemiol (1967) 1.31
An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol (1984) 1.30
Pathogenesis of West Nile Virus encephalitis in mice and rats. 1. Influence of age and species on mortality and infection. Am J Epidemiol (1967) 1.28
Pathogenesis of type 1 dengue virus infection in suckling, weanling and adult mice. 1. The relation of virus replication to interferon and antibody formation. Am J Epidemiol (1969) 1.28
Organization of the middle RNA segment of snowshoe hare Bunyavirus. Virology (1988) 1.26
Quantitative correlation between barrel-field size and the sensory innervation of the whiskerpad: a comparative study in six strains of mice bred for different patterns of mystacial vibrissae. J Neurosci (1986) 1.25
Altered sensory processing in the somatosensory cortex of the mouse mutant barrelless. Science (1996) 1.24
Histological studies of the monkey neurovirulence of group B arboviruses. I. A semiquantitative grading scale. Am J Epidemiol (1965) 1.24
Human immunodeficiency virus type 1 causes productive infection of macrophages in primary placental cell cultures. J Infect Dis (1994) 1.24
Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses. Virology (1982) 1.23
Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21
Abrogation of genetically controlled resistance of mice to Treponema pallidum by irradiation. Nature (1980) 1.21
Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. J Immunol (1976) 1.20
The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol (1978) 1.19
Ultrastructure of giant and small thalamic terminals of cortical origin: a study of the projections from the barrel cortex in mice using Phaseolus vulgaris leuco-agglutinin (PHA-L). Exp Brain Res (1991) 1.19
Acute rabies death mediated by antibody. Nature (1981) 1.17
Completion of the La Crosse virus genome sequence and genetic comparisons of the L proteins of the Bunyaviridae. Virology (1995) 1.16
Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies. J Virol (1995) 1.13
Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion. Virology (1993) 1.13
An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function. J Virol (1985) 1.12
Inhibition by cyclosporin A of rodent malaria in vivo and human malaria in vitro. Infect Immun (1982) 1.10
In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res Hum Retroviruses (1990) 1.09
Cerebellar hypoplasia in neonatal rats caused by lymphocytic choriomeningitis virus. Science (1971) 1.09
Immunosuppression: a means to assess the role of the immune response in acute virus infections. Fed Proc (1972) 1.09
Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses. Annu Rev Microbiol (1993) 1.08
Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol (1983) 1.07
A magnetic device to stimulate selected whiskers of freely moving or restrained small rodents: its application in a deoxyglucose study. Brain Res (1985) 1.07
Forms and measures of adult and developing human corpus callosum: is there sexual dimorphism? J Comp Neurol (1989) 1.07
Cross-protection against lymphocytic choriomeningitis virus mediated by a CD4+ T-cell clone specific for an envelope glycoprotein epitope of Lassa virus. J Virol (1993) 1.06
Experimental visna in Icelandic sheep: the prototype lentiviral infection. Rev Infect Dis (1985) 1.06
Organization of feedback and feedforward projections of the barrel cortex: a PHA-L study in the mouse. Exp Brain Res (1988) 1.05
Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med (1996) 1.04
Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment. J Virol (1991) 1.03
Early lesions of mouse vibrissal follicles:: their influence on dendrite orientation in the cortical barrelfield. Exp Brain Res (1980) 1.03
Virulence of La Crosse virus is under polygenic control. J Virol (1986) 1.02
A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science (1987) 1.02
Histological studies of the monkey neurovirulence of group B arboviruses. II. Selection of indicator centers. Am J Epidemiol (1966) 1.02
Development of the barrels and barrel field in the somatosensory cortex of the mouse. J Comp Neurol (1977) 1.02
Selective breeding for variations in patterns of mystacial vibrissae of mice. Bilaterally symmetrical strains derived from ICR stock. J Hered (1986) 1.02
The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963. Am J Epidemiol (1995) 1.02
The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein. J Gen Virol (1989) 1.01
Synaptic development in human cerebral cortex. Int J Neurol (1989) 1.01
Effect of antilymphocyte serium on tacaribe virus infection in infant mice. Infect Immun (1971) 1.01
Allogeneic H-2 antigen expression is insufficient for tumor rejection. Proc Natl Acad Sci U S A (1987) 1.00
Epidemiology of multiple sclerosis: critique of the evidence for a viral etiology. Am J Epidemiol (1978) 1.00
Variation in pattern of mystacial vibrissae in mice. A quantitative study of ICR stock and several inbred strains. J Hered (1984) 0.99
Histological studies of the monkey neurovirulence of group B arboviruses. IV. Evaluation of an attenuated strain (E5) of Langat virus. Am J Epidemiol (1968) 0.98
Polygenic control of neuroinvasiveness in California serogroup bunyaviruses. J Virol (1993) 0.98
The long-distance effects of brain lesions: visualization of myelinated pathways in the human brain using polarizing and fluorescence microscopy. J Neuropathol Exp Neurol (1991) 0.97